Eun Mi Park
Ewha Womans University
194 Papers
1.1K Citations
Eun Mi Park is an academic researcher from Ewha Womans University. The author has contributed to research in topics: Proinflammatory cytokine & Neuroprotection. The author has an hindex of 38, co-authored 186 publications. Previous affiliations of Eun Mi Park include Food and Drug Administration & Roswell Park Cancer Institute.
Chat about Author
Papers
Echocardiographic epicardial fat thickness and coronary artery disease.
Jin-Won Jeong,Myung Ho Jeong,Kyeong Ho Yun,Seok Kyu Oh,Eun Mi Park,Yun Kyung Kim,Sang Jae Rhee,Eun Mi Lee,Je Lee,Nam Jin Yoo,Nam-Ho Kim,Jong Chun Park +11 more
TL;DR: Epicardial fat thickness was significantly correlated with the severity of coronary artery disease in patients with known coronary artery diseased in a clinical setting.
401
Oxidative Damage in Tissues of Rats Exposed to Cigarette Smoke
TL;DR: The results verified that the lung is a primary target of cigarette smoke-induced oxidative damage, and cigarette smoke exerts its oxidative effects on the rest of the entire organs eventually.
167
Prx1 Suppresses Radiation-Induced c-Jun NH2-Terminal Kinase Signaling in Lung Cancer Cells through Interaction with the Glutathione S-Transferase Pi/c-Jun NH2-Terminal Kinase Complex
TL;DR: It is found that overexpression of Prx1 enhances the clonogenic survival of irradiated cells and suppresses ionizing radiation-induced c-Jun NH2-terminal kinase (JNK) activation and apoptosis.
159
Anti-Inflammatory Mechanism of Compound K in Activated Microglia and Its Neuroprotective Effect on Experimental Stroke in Mice
Jin Sun Park,Jin A. Shin,Ji Sun Jung,Jin Won Hyun,Thi Kim Van Le,Dong-Hyun Kim,Eun Mi Park,Hee Sun Kim +7 more
TL;DR: Compound K reduced the infarct volume of ischemic brain induced by middle cerebral artery occlusion and suppressed microglial activation in the isChemic cortex, suggesting that compound K is a promising agent for prevention and/or treatment of cerebral ischemia and other neuroinflammatory disorders.
135
The beneficial effect of high loading dose of rosuvastatin before percutaneous coronary intervention in patients with acute coronary syndrome.
Kyeong Ho Yun,Myung Ho Jeong,Seok Kyu Oh,Sang Jae Rhee,Eun Mi Park,Eun Mi Lee,Nam Jin Yoo,Nam-Ho Kim,Young Keun Ahn,Jin-Won Jeong +9 more
TL;DR: Single high dose of rosuvastatin prior to PCI reduces periprocedural myocardial injury in patients with acute coronary syndrome.
127